{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:15:51Z","timestamp":1790349351231,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jlr.2022.100237","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T20:25:40Z","timestamp":1654287940000},"page":"100237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy"],"prefix":"10.1016","volume":"63","author":[{"given":"Mingjuan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Kutrolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-3952","authenticated-orcid":false,"given":"Anne","family":"Sadewasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3187","authenticated-orcid":false,"given":"Sven","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh Motamedi","family":"Joibari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jaschinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Olivecrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-7734","authenticated-orcid":false,"given":"Sander","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2022.100237_bib1","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2022.100237_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2022.100237_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOL.0000000000000676","article-title":"Regulation of lipoprotein lipase-mediated lipolysis of triglycerides","volume":"31","author":"Basu","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2022.100237_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MOL.0000000000000600","article-title":"New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk","volume":"30","author":"Kersten","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2022.100237_bib5","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","article-title":"Atypical angiopoietin-like protein that regulates ANGPTL3","volume":"109","author":"Quagliarini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100237_bib6","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","article-title":"Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism","volume":"303","author":"Ren","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2022.100237_bib7","first-page":"70","article-title":"Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans","volume":"119","author":"Romeo","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100237_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/17460875.1.2.227","article-title":"Fasting-induced adipose factor\/Angiopoietin-like protein 4: a potential target for dyslipidemia","volume":"1","author":"Zandbergen","year":"2006","journal-title":"Future Lipidol."},{"key":"10.1016\/j.jlr.2022.100237_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","article-title":"Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels","volume":"424","author":"Zhang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2022.100237_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","article-title":"Angptl3 regulates lipid metabolism in mice","volume":"30","author":"Koishi","year":"2002","journal-title":"Nat.Genet."},{"key":"10.1016\/j.jlr.2022.100237_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and Cardiovascular Disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100237_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100237_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","article-title":"Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease","volume":"48","author":"Helgadottir","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2022.100237_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100237_bib15","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene","volume":"275","author":"Kersten","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100237_bib16","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2022.100237_bib17","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.M067363","article-title":"Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes","volume":"57","author":"Dijk","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib18","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1074\/jbc.RA118.002426","article-title":"Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3\/furin in adipocytes","volume":"293","author":"Dijk","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100237_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1194\/jlr.ILR120000780","article-title":"ANGPTL4 inactivates lipoprotein lipase by catalyzing the irreversible unfolding of LPL's hydrolase domain","volume":"61","author":"Kristensen","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib20","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.jlr.2022.100237_bib21","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.0604026103","article-title":"Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue","volume":"103","author":"Sukonina","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100237_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of Coronary Artery Disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100237_bib23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among \u223c300,000 multi-ethnic participants of the million veteran program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2022.100237_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2018.2866","article-title":"Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes","volume":"3","author":"Lotta","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jlr.2022.100237_bib25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","author":"Myocardial Infarction","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2022.100237_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","article-title":"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL","volume":"39","author":"Romeo","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2022.100237_bib27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2022.100237_bib28","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1194\/jlr.M094128","article-title":"Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice","volume":"60","author":"Oteng","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib29","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1073\/pnas.0705041104","article-title":"Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice","volume":"104","author":"Desai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100237_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97918","article-title":"Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis","volume":"3","author":"Aryal","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/j.jlr.2022.100237_bib31","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1038\/s41598-021-87020-5","article-title":"Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice","volume":"11","author":"Spitler","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2022.100237_bib32","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1194\/jlr.M400138-JLR200","article-title":"Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4","volume":"45","author":"Ge","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140989","article-title":"Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice","volume":"131","author":"Singh","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2022.100237_bib34","doi-asserted-by":"crossref","first-page":"E464","DOI":"10.1152\/ajpendo.00144.2021","article-title":"Chronic high-fat feeding and prolonged fasting in liver-specific ANGPTL4 knockout mice","volume":"321","author":"Spitler","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2022.100237_bib35","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","article-title":"Design of antisense oligonucleotides stabilized by locked nucleic acids","volume":"30","author":"Kurreck","year":"2002","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jlr.2022.100237_bib36","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonucleotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2022.100237_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.jlr.2022.100237_bib38","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/nar\/gkx060","article-title":"Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor","volume":"45","author":"Schmidt","year":"2017","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.jlr.2022.100237_bib39","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2022.100237_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-2727-2_9","article-title":"Design and selection of antisense oligonucleotides targeting transforming growth factor beta (TGF-beta) isoform mRNAs for the treatment of solid tumors","volume":"1317","author":"Jaschinski","year":"2015","journal-title":"Met. Mol. Biol."},{"key":"10.1016\/j.jlr.2022.100237_bib41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.omtn.2019.04.018","article-title":"Anti-Niemann Pick C1 single-stranded oligonucleotides with locked nucleic acids potently reduce Ebola virus infection in\u00a0vitro","volume":"16","author":"Sadewasser","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jlr.2022.100237_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jacl.2018.02.006","article-title":"Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue","volume":"12","author":"Dijk","year":"2018","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2022.100237_bib43","doi-asserted-by":"crossref","first-page":"34511","DOI":"10.1074\/jbc.M806067200","article-title":"Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice","volume":"283","author":"Weinstein","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100237_bib44","doi-asserted-by":"crossref","first-page":"34411","DOI":"10.1074\/jbc.M403058200","article-title":"The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF\/PGAR\/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment","volume":"279","author":"Mandard","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100237_bib45","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1194\/jlr.M070813","article-title":"An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1","volume":"57","author":"Allan","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1194\/jlr.D010744","article-title":"Determination of lipoprotein lipase activity using a novel fluorescent lipase assay","volume":"52","author":"Basu","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08428","article-title":"ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure","volume":"4","author":"Dijk","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.jlr.2022.100237_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6793-4-13","article-title":"Effects of heparin on the uptake of lipoprotein lipase in rat liver","volume":"4","author":"Neuger","year":"2004","journal-title":"BMC Physiol."},{"key":"10.1016\/j.jlr.2022.100237_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/154545704322988021","article-title":"Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA)","volume":"14","author":"Vollmer","year":"2004","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.jlr.2022.100237_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molmet.2017.06.007","article-title":"Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting","volume":"6","author":"Cushing","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2022.100237_bib51","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism","volume":"146","author":"Koster","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jlr.2022.100237_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6793-12-13","article-title":"Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue","volume":"12","author":"Kroupa","year":"2012","journal-title":"BMC Physiol."},{"key":"10.1016\/j.jlr.2022.100237_bib53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00125-018-4583-5","article-title":"Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota","volume":"61","author":"Janssen","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2022.100237_bib54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2022.100237_bib55","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2022.100237_bib56","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes","volume":"9","author":"Gusarova","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2022.100237_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1194\/jlr.M065011","article-title":"Regulation of plasma lipid homeostasis by hepatic lipoprotein lipase in adult mice","volume":"57","author":"Liu","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2022.100237_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmet.2013.11.004","article-title":"Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion","volume":"3","author":"Mattijssen","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2022.100237_bib59","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/db10-0145","article-title":"Hypothalamic Angptl4\/Fiaf is a novel\u00a0regulator of food intake and body weight","volume":"59","author":"Kim","year":"2010","journal-title":"Diabetes"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227522000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:31:21Z","timestamp":1758306681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227522000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0022227522000700"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100237","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2022.100237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100237"}}